Wrong life for 28 years, claim 2.73 million! The risk of liver cancer that you don't know about.

On September 5th, the much-watched "28 Years of Mistakes in Life" event made new progress.
,730,000 claims against the hospital, and the case will go to trial next week.
February this year, 28-year-old Yao Ze was found to have liver cancer, his "birth mother" want to cut the liver to save the son, found that his son is not a real blood relative, thus revealing the "wrong life for 28 years" story.
The original year to assist in the production of YaoZe, Henan University Huaihe Hospital related personnel work errors, resulting in two mothers holding the wrong child, and Yao Ze's birth mother suffering from hepatitis B big three yang, that is, hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), hepatitis B core antibody (anti-HBC) three are positive, and mother-to-child transmission is one of the most important transmission routes of hepatitis B virus.
Yao Ze's lawyer believes that because of the hospital's work mistakes, Yao Ze was born "wrongly hugged", resulting in his separation from the custody of his biological parents, so that it failed to carry out timely hepatitis B immunization measures, at the age of 28 years old will suffer from advanced liver cancer.
fate of Yao Ze opened a lot of "joke", although he is optimistic face, but the pain of advanced liver cancer, treatment costs and other pressures will continue to hit his body and spirit.
according to the latest data released by GLOBOCAN 2018, the number of new cases of liver cancer worldwide reached 841,000, ranking 6th in malignant tumors and 782,000 deaths, ranking 2nd in malignant tumors.
Primary liver cancer is particularly high in China, is the fourth most common malignant tumor and the second cause of cancer death, liver cancer annual new cases reached 466,000 people, 422,000 deaths, accounting for 55.4% and 53.9% of the world, respectively.
addition, the vast majority of liver cancer in China is found to be in the middle and late stage, often lose excellent treatment opportunities, and liver cancer prognosis is poor, in China's five-year survival rate of only 12.1%.
and liver cancer treatment is expensive, generally not less than 500,000, often millions, to the patient's family has brought a lot of financial pressure.
According to documents released by the American Cancer Society, several factors increase a person's risk of developing liver cancer, including the following: 1 Gender liver cancer is more common in men than in women, largely because behaviors such as smoking and alcohol influence some of the risk factors described below.
2 Chronic viral hepatitis Worldwide, the most common risk factor for liver cancer is chronic (long-term) infection with hepatitis B virus (HBV) or hepatitis C virus (HCV).
these infections can lead to cirrhosis and liver cancer, a trilogy called liver cancer development.
, hepatitis C infection is a common cause of liver cancer in the United States, while hepatitis B is more common in Asia and developing countries.
people infected with both viruses are at high risk of developing chronic hepatitis, cirrhosis and liver cancer.
risk of developing liver cancer is higher if these people drink alcohol at the same time (at least six alcoholic drinks a day).
3 Cirrhosis is a disease in which liver cells are damaged and replaced by scar tissue, and patients with cirrhosis have a higher risk of liver cancer, and most, but not all, people with liver cancer already have some evidence of cirrhosis.
4 non-alcoholic fatty liver non-alcoholic fatty liver is a common disease in obese people.
a subtype of the disease, non-alcoholic fatty hepatitis (NASH), which can develop into cirrhosis and further develop into liver cancer.
5 primary bile cirrhosis some autoimmune diseases affecting the liver can also lead to cirrhosis.
, for example, in primary bile cirrhosis (PBC), damage or even damage to the bile tubes in the liver can lead to cirrhosis of the liver, while patients with advanced PBC have a high risk of liver cancer.
6 genetic metabolic diseases some genetic metabolic diseases can lead to cirrhosis of the liver.
people with hereditary hemoglobinism absorb too much iron from food, which is deposited in various tissues of the body, including the liver.
if enough iron is accumulated in the liver, it can lead to cirrhosis and liver cancer.
7 alcoholism is the leading cause of cirrhosis in the United States, which in turn increases the risk of liver cancer, as well as in our country.
8 Smoking increases the risk of liver cancer, and people who have quit smoking have a lower risk than those who smoke, but both groups have a higher risk than those who never smoke.
9 obese (very overweight) increases the risk of liver cancer, possibly because it causes fatty liver and cirrhosis.
type 2 diabetes is associated with an increased risk of liver cancer, and there are often other risk factors, such as alcoholism and/or chronic viral hepatitis.
because people with type 2 diabetes tend to be overweight or obese, which in turn can lead to liver problems.
11 Some rare diseases, including tyrosineemia, alpha1 antitrypsin deficiency, delayed skin rickets, glycogen deposition disease, and liver bean-like nuclear degeneration, also increase the risk of liver cancer.
12 Carcinogens such as aflatoxin are produced by a fungus that contaminates peanuts, wheat, soybeans, tree nuts, corn and rice and causes the fungus to grow in a humid and warm environment, and long-term exposure to these substances is a major risk factor for liver cancer.
13 vinyl chloride and thorium dioxide increases the risk of hepatovascular sarcoma.
14 anabolic steroid anabolic steroids are the male hormones that some athletes use to increase strength and muscle mass.
long-term use of anabolic steroids may slightly increase the risk of liver cancer, but can-loose steroids do not have such risks as hydrogenated pine, strong pine and dexamisong.
in the face of so many carcinogenic factors, in the face of liver cancer, human beings are not completely helpless.
Because chronic hepatitis B infection can lead to cirrhosis and liver cancer, in addition to daily restrictions on drinking and smoking, maintaining a healthy weight, and actively treating diseases that increase the risk of liver cancer, studies have found that vaccination against hepatitis B virus protects people from liver cancer caused by hepatitis B virus.
according to the National Immunization Programme's Childhood Immunization Procedures and Notes (2016 edition), recombinant hepatitis B vaccine-87, or HepB, requires three doses in a row, the first of which is in newborns. Inoculated within 24 h of birth, the second dose at the age of 1 month, the third dose at the age of 6 months, and newborns born to HBsAg-positive or unknown mothers should be vaccinated against hepatitis B as early as possible within 24 h of birth.
born to a HBsAg-positive mother may, as directed by the doctor, be vaccinated against hepatitis B at the same time as the first dose of hepatitis B vaccine is given at different (body) sites, and 100 I Units of hepatitis B immunoglobulin (HBIG) can be injected in different parts of the muscle.
addition, HBsAg and anti-HBs tests are recommended for children born to HBsAg-positive mothers after 1 to 2 months of the 3rd dose of hepatitis B vaccine.
if HBsAg negative, anti-HBs 10 mIU/ml are found, three more doses of hepatitis B vaccine can be given in accordance with the 0, January and June immunization procedures.
1 liver cancer surgery is surgical removal (surgical removal of tumors) or liver transplantation.
2 liver cancer ablation is a treatment that destroys tumors without removing them.
techniques can be applied to patients with small tumors when surgery is not the best option because of poor health or reduced liver function.
they are less likely to cure cancer than surgery, but they are helpful for some patients, who are sometimes used in patients waiting for a liver transplant.
is best used in tumors with a diameter of no more than 3 cm, and for slightly larger tumors (3 to 5 cm wide), it can be used with embolism.
because ablation usually destroys some of the normal tissue around the tumor, it may not be a good choice for treating tumors near large blood vessels, shin muscles, or bold tubes.
embolism treatment for hepatic cancer is a procedure that injects substances directly into the arteries of the liver to block or reduce blood flow to liver tumors.
the liver is that it has two blood supplies.
most normal liver cells are blood from the door veins, while cancer in the liver is mainly blood from the liver arteries, blocking the part of the liver artery that supplies blood to the tumor helps kill cancer cells.
embolism is an option for patients who are unable to surgically remove the tumor.
can be used in patients with tumors that are too large to be treated with ablation (usually larger than 5 cm in diameter) and have sufficient liver function, it can also be used with ablation.
embolism can reduce part of the blood supply to normal liver tissue, so embolism may not be a good option for some patients with liver damage due to diseases such as hepatitis or cirrhosis, and it is not clear which type of embolism has better long-term effects.
radiation therapy for 4 liver cancers uses high-energy rays (or particles) to kill cancer cells.
may not be a good option for patients with severe liver damage due to diseases such as hepatitis or cirrhosis.
Radiation therapy can help treat: . . . liver cancer that cannot be surgically removed . . . liver cancer that cannot be surgically removed . . . liver cancer that cannot be treated with ablation or embolism or that has not responded well to these treatments . . . liver cancer has spread to other areas, such as the brain or bones . . . people who have a tumor thrombosis (a collection of liver cancer cells) 5 liver cancer targeted drug treatment As researchers learn more about the cell changes that cause cancer, they have been able to develop new drugs for these changes.
targeted drugs are different from standard chemotherapy drugs and often have different side effects.
like chemotherapy, these drugs enter the bloodstream and reach almost every part of the body, which makes them useful for cancers that have spread to other parts of the body.
because standard chemotherapy is not very effective in most liver cancer patients, doctors are more focused on targeted therapies.
6 liver cancer immunotherapy is the use of drugs to help the body's own immune system find and destroy cancer cells.
it can be used to treat some liver cancer patients.
an important part of the immune system is its ability to prevent itself from attacking normal cells in the body.
to do this, it uses "checkpoints", proteins on immune cells, to turn on (or off) to initiate an immune response.
cancer cells sometimes use these checkpoints to avoid being attacked by the immune system, and new drugs targeted at these checkpoints are promising in treating liver cancer.
chemotherapy (chemo) for liver cancer is a drug used to destroy the treatment of cancer cells.
chemotherapy may be an option for patients who are unable to undergo surgical treatment, who are not performing well with local treatments such as ablation or embolism, or who are no longer effective in targeted treatment.
, most chemotherapy drugs do not have a significant effect on liver cancer.
recent studies have shown that combination medications may be more effective than using only one chemotherapy drug.
these combinations can shrink only a small number of tumors, and the response usually doesn't last long.
most studies have shown that systemic chemotherapy does not extend a patient's life.
most common chemotherapy drugs used to treat liver cancer include gistabin, oxalipalin, cisplatin, dorobi, 5-fluorouracil, capedabin, and mitothoquine.
sometimes, two or three drugs are used in a combined way.
GEMOX (Gissythabinga Osali platinum) is a fairly healthy option for people who may be resistant to multiple drugs.
5-FU-based chemotherapy, such as FOLFOX (5-FU, Osali platinum and filthic acid), is another option for patients with severe liver disease.
Looking back on the wrong life for 28 years Yao Ze because of missed hepatitis B blocking needle, from hepatitis B eventually developed to the advanced stage of liver cancer, sincerely wish him adhere to treatment, through the existing treatment technology slowly extend the length of life.
source: Clinical front !-- end of content presentation -- !-- to determine whether the login is over.